Effects of hydroxycamptothecin on TGFβ1, α-SMA and collagen I expression in rat hepatic satellite cells
Guo-xin HU,Zan-yan WAN,Jia-liang SHAO,Yi ZHANG,Lun-li ZHANG,Zuo-jiong GONG
DOI: https://doi.org/10.3760/cma.j.issn.1007-3418.2012.06.015
2012-01-01
Abstract:Objective To investigate the molecular mechanism of hydroxycamptothecin (HCPT)mediated anti-hepatic fibrosis by evaluting its effects on expression of tumor growth factor-beta 1 (TGFβ1),alpha-smooth muscle actin (α-SMA) and collagen I (Col I) in hepatic satellite cells (HSCs).Methods Cultured HSCs were treated with different concentrations of HCPT:low-dose group,0.25 mg/L; middle-dose group,0.5 mg/L; high-dose group,0.75 mg/L; and control group,0mg/L.Cell proliferation was assessed by the MTT assay.The mRNA expressions of TGFβ1,α-SMA and Col I were determnined by reverse transcriptionpolymerase chain reaction.The protein expressions of TGFβ1 and α-SMA were detected by Western blot.The content of Col I in the cultured HSCs' supernatant was measured by enzyme-linked immunosorbent assay.Results The MTT absorbance values of the low-dose group (0.631 ±0.074),middle-dose group (0.469±0.012) and high-dose group (0.200± 0.001) were significantly lower than that of the control group (0.793 ±0.098;F=82.86,P<0.01).Compared with the control group,the HCPT-treated groups showed significantly downregulated gene expressions of TGFβ1 (control:0.716±0.064 vs.low:0.611 ±0.040,middle:0.510±0.014,high:0.403 ± 0.026),α-SMA (control:0.696 ± 0.075 vs.low:0.579 ± 0.037,middle:0.470 ± 0.024,high:0.299 ± 0.017),and Col I (control:1.019±0.056 vs.low:0.835±0.022,middle:0.696±0.055,high:0.322±0.104) (all,P<0.01).Meanwhile,HCPT-treated HSCs showed significantly reduced protein expressions of TGFβI (control:0.872±0.053 vs.low:0.654±0.047,middle:0.545±0.002,high:0.436±0.039) and α-SMA (control:0.858±0.050 vs.low:.0.620±0.045,middle:0.525 ±0.042,high:0.434±0.052) (all,P<0.01).The Col I levels secreted by HSCs were significantly lower in the HCPT-treated groups (low:168.367±16.453 ng/ml; middle:141.2844±11.731 ng/ml; high:132.910± 10.048 ng/ml) than in the control group (188.733 ± 18.299ng/ml) (all,P<0.01).Conclusions The mechanism of HCPT-mediated anti-hepatic fibrosis may involve down-regulation of TGFβ1 expression to inhibit HSC proliferation and activation,as well as reduction of Col I synthesis and secretion.